Top 5 game-changing drug delivery techs

MicroneedleIt is not enough to invent a potential new miracle drug. If there is no efficient way to get the therapeutic to exactly where it is needed, without harming healthy cells, then the drug is no "miracle" at all. If the drug produces so many unpleasant side effects that patient compliance becomes an issue, development is far from over. This remains true not only with drugs that are in development, but even those that are already on the market. Just because it has been approved by the FDA and is being successfully and safely used by consumers does not mean development of that drug is over.

What new delivery methods bring to the table are not only unique ways to continue innovating even after the therapeutic goes off patent, but the ability to give relief to patients who may be suffering from drug side effects.

The drug delivery industry is not only alive and well, but could be booming in the near future. Here are the top five technologies catching drugmakers' attention.

Click here to see the report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.